Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (221-230 of 522) with videos related to

Pageof 53
Sort By:
The Journal of Urology|October 9, 2003
Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURESusan R Harlan, Matthew R Cooperberg, Eric P Elkin, et al.
The Journal of Urology|September 5, 2018
Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active SurveillanceZachary Kornberg, Janet E Cowan, Antonio C Westphalen, et al.
JAMA Oncology|November 11, 2021
Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer ScreeningMichael S Leapman, Rong Wang, Henry Park, et al.
The Journal of Urology|March 16, 2004
The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registryMatthew R Cooperberg, Jeanette M Broering, Mark S Litwin, et al.
JAMA Network Open|January 27, 2025
Trends in Prostate Cancer Incidence and Mortality RatesErin L Van Blarigan, Meg A McKinley, Samuel L Washington, et al.
The Journal of Urology|May 10, 2005
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomyMatthew R Cooperberg, David J Pasta, Eric P Elkin, et al.
Urology|May 28, 2013
Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA eraAllison S Glass, Janet E Cowan, Mahesh J Fuldeore, et al.
The Journal of Urology|April 27, 2019
A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active SurveillanceZachary Kornberg, Matthew R Cooperberg, Janet E Cowan, et al.
Urology|August 11, 2020
Significant Management Variability of Urethral stricture Disease in United States: Data from the AUA Quality (AQUA) RegistryAndrew J Cohen, Nnenaya Agochukwu-Mmonu, Danil V Makarov, et al.
European Urology|September 6, 2018
Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical ProstatectomyMichael S Leapman, Hao G Nguyen, Janet E Cowan, et al.
Pageof 53

Showing results (221-230 of 522) with videos related to

Sort By:
Pageof 53
The Journal of Urology|October 9, 2003
Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURESusan R Harlan, Matthew R Cooperberg, Eric P Elkin, et al.
The Journal of Urology|September 5, 2018
Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active SurveillanceZachary Kornberg, Janet E Cowan, Antonio C Westphalen, et al.
JAMA Oncology|November 11, 2021
Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer ScreeningMichael S Leapman, Rong Wang, Henry Park, et al.
The Journal of Urology|March 16, 2004
The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registryMatthew R Cooperberg, Jeanette M Broering, Mark S Litwin, et al.
JAMA Network Open|January 27, 2025
Trends in Prostate Cancer Incidence and Mortality RatesErin L Van Blarigan, Meg A McKinley, Samuel L Washington, et al.
The Journal of Urology|May 10, 2005
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomyMatthew R Cooperberg, David J Pasta, Eric P Elkin, et al.
Urology|May 28, 2013
Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA eraAllison S Glass, Janet E Cowan, Mahesh J Fuldeore, et al.
The Journal of Urology|April 27, 2019
A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active SurveillanceZachary Kornberg, Matthew R Cooperberg, Janet E Cowan, et al.
Urology|August 11, 2020
Significant Management Variability of Urethral stricture Disease in United States: Data from the AUA Quality (AQUA) RegistryAndrew J Cohen, Nnenaya Agochukwu-Mmonu, Danil V Makarov, et al.
European Urology|September 6, 2018
Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical ProstatectomyMichael S Leapman, Hao G Nguyen, Janet E Cowan, et al.
Pageof 53